Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06999967 · ClinicalTrials.gov registry record
Stanford-Lucidify EEG Delirium Study
A clinical trial, sponsored by Stanford University.
- Not yet
- Registry status
- 80
- Enrollment target
NCT06999967: Clinical Trial study, sponsored by Stanford University.
NCT06999967 is a clinical trial that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06999967 has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of the CGX/Lucidify EEG system in enabling physicians to detect delirium (confusion) in medically ill patients as early as possible in order to minimize the detrimental effects of delirium. The study will involve collecting EEG data through the CGX EEG system (a Research-grade 2-Channel EEG device) and applying the Lucidify EEG software algorithm to identify indicators and degree of delirium, obtain data regarding the amount and degree of patient's movement and activity throughout the day in order to detail delirium subtype, and obtain data regarding the quality of the sleep as it affects delirium severity and duration. By enhancing early detection, this research aims to improve patient outcomes and inform clinical decision-making.
Interventions
- DIAGNOSTIC_TEST Electroencephalogram (EEG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2026-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06999967
The ClinicalTrials.gov registry entry for NCT06999967 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electroencephalogram (EEG) is the first listed.
NCT06999967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06999967 about?
NCT06999967 is a clinical study titled "Stanford-Lucidify EEG Delirium Study". The purpose of this study is to evaluate the effectiveness of the CGX/Lucidify EEG system in enabling physicians to detect delirium (confusion) in medically ill patients as early as possible in order to minimize the detrimental effects of delirium. The study will involve collecting EEG data through ...
What is the current status of trial NCT06999967?
This trial is currently not yet recruiting. The enrollment target is 80 participants. The study started on 2025-06-01. Estimated completion is 2026-05-30.
What interventions are being tested in trial NCT06999967?
The interventions under investigation include: Electroencephalogram (EEG) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06999967?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.